ID: ALA195158

Max Phase: Preclinical

Molecular Formula: C17H17FO4

Molecular Weight: 304.32

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1ccc(/C=C\c2cc(O)c(OC)c(OC)c2)cc1F

Standard InChI:  InChI=1S/C17H17FO4/c1-20-15-7-6-11(8-13(15)18)4-5-12-9-14(19)17(22-3)16(10-12)21-2/h4-10,19H,1-3H3/b5-4-

Standard InChI Key:  AUGRINRVIWUUFL-PLNGDYQASA-N

Associated Targets(Human)

Tubulin beta-1 chain 182 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 304.32Molecular Weight (Monoisotopic): 304.1111AlogP: 3.73#Rotatable Bonds: 5
Polar Surface Area: 47.92Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 9.88CX Basic pKa: CX LogP: 3.68CX LogD: 3.68
Aromatic Rings: 2Heavy Atoms: 22QED Weighted: 0.86Np Likeness Score: 0.24

References

1. Ducki S, Mackenzie G, Lawrence NJ, Snyder JP..  (2005)  Quantitative structure-activity relationship (5D-QSAR) study of combretastatin-like analogues as inhibitors of tubulin assembly.,  48  (2): [PMID:15658859] [10.1021/jm049444m]

Source